Our May Clinical Grand Rounds will be presented by, Dr. Michael Giles, CEO Sonara Health, and Dr. Mark McGovern: Professor / Co-Chief, Division of Public Mental Health & Population Sciences, Department of Psychiatry / Medical Director, Integrated Behavioral Health, Division of Primary Care, Department of Medicine, Stanford University School of Medicine. They will be presenting on, ““Can We Harness Technology to Build Trust and Adherence in Opioid Treatment Programs?”
Here is a synopsis and objectives for the presentation:
Opioid treatment programs manage patients with severe opioid use disorder under highly regulated conditions. These federal regulations were designed to foster medication adherence and prevent diversion, while also helping patients to control cravings, restore functioning, and reap the benefits of medication-assisted recovery. However, some patients may not respond well to the relatively stringent requirements, either early on in their treatment, or even over time. In March 2020, in response to COVID-19, SAMHSA relaxed take-home dose guidelines for patients. Recent research reveals that the relaxation of take-homes has not led to an increase in methadone overdose deaths or diversion of doses. In this presentation, we describe the development and evaluation of Sonara, an app designed to build trust and support adherence to methadone take-home dosing. Sonara is a smartphone-based app for patient monitoring that combines video-recording with tamper-aware packaging on take-home methadone vials. We describe patient, clinician and clinic leader experiences and outcomes with Sonara from four diverse clinics in California, Massachusetts, New Mexico and Oklahoma. Discussion can focus on the potential application of Sonara in standard opioid treatment program operations. Explain how strengthening patient-provider trust leads to improved OTP accessibility Describe how asynchronously observed MAT can be used to help patients meet their recovery goals faster List SAMHSA’s new, more stringent take-home requirements, set to take-effect after the COVID public health emergency has expired MGiles Photo - CGR 061523 MMcGovern-Photo---CGR-061523 Michael Giles, MD & Mark McGovern, PhD Dr. Giles: CEO Sonara Health Dr. McGovern: Professor / Co-Chief, Division of Public Mental Health & Population Sciences, Department of Psychiatry / Medical Director, Integrated Behavioral Health, Division of Primary Care, Department of Medicine, Stanford University School
21 май 2023
